19 Jun Conversion d’OCABSA
Paris, France et Camberley, UK – 19 juin 2019 - Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT) annonce qu'en vertu du programme de financement par des Obligations Convertibles...
Paris, France et Camberley, UK – 19 juin 2019 - Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT) annonce qu'en vertu du programme de financement par des Obligations Convertibles...
Paris, France and Camberley, UK – 19 June 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with...
Paris, France et Camberley, UK – 14 juin 2019 - Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT) annonce qu'en vertu du programme de financement par des Obligations Convertibles assorties de warrants...
Paris, France and Camberley, UK – 14 June 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme...
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers https://novacyt.com/wp-content/uploads/2019/06/NOVACYT_CP_Droits-de-vote_2019-Juin.pdf ...
Paris, France and Camberley, UK – 3 June 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares...
Paris, France et Camberley, Royaume-Uni - 24 mai 2019 - Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce aujourd'hui la publication du rapport...
Paris, France and Camberley, UK – 24 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces that the Company’s Annual Report and...
Paris, France and Camberley, UK – 17 May 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme...
Paris, France et Camberley, UK – 17 mai 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), spécialiste international du diagnostic Clinique, annonce qu'en vertu du Programme de Financement par Obligations Convertibles assorties de Warrants annoncé...
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |